Dr. Oliver F. Adunka, MD

Dr. Adunka practices at Osu Eye And Ear Institute in Columbus, Ohio.

Dr. Adunka's NPI, 1316975444, was assigned on June 29, 2006. Dr. Adunka graduated from University of Vienna Faculty of Medicine in 1999. Dr. Adunka holds Ohio license 35123953.

Dr. Adunka's primary practice is Osu Eye and Ear Institute, at 915 Olentangy River Rd Fl 4 Fl 4, Columbus, OH 43212. The practice phone is (614) 366-3687.

Dr. Adunka's primary practice is Osu Eye And Ear Institute in Columbus, Ohio. Dr. Adunka is also affiliated with Ohio State University Hospital. The medical group on file is Nationwide Children's Hospital. Dmand AI also links Dr. Adunka to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adunka practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Adunka's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Adunka is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Adunka's licenses on file in 2 states: Ohio and North Carolina.

Dmand AI lists chronic nasal allergies, ear eustachian tube disorders, ear infection, hearing loss and impairment, swimmer's ear, tinnitus and vertigo among the conditions Dr. Adunka treats.

CMS data shows 252 Medicare services from Dr. Adunka across 5 procedure codes in 2024, for 191 Medicare patients. Medicare paid $36,140 for them.

CMS counts 191 Medicare patients who saw Dr. Adunka in 2024. The largest group is 65 to 74, with 86 patients. 71% of them have high cholesterol, and 66% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Adunka's median patient age at 57, with 54% women.

In 2024, Dr. Adunka wrote 56 Medicare Part D claims for 28 patients. 91% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $85 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Dr. Adunka accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 189 papers to Dr. Adunka, published from 2005 to 2025. 2023 was the busiest year, with 10. The most frequent topics are Cochlear Implantation, Cochlear Implants and Speech Perception. Dr. Adunka has published most often in Otol Neurotol. Dr. Adunka's most frequent co-authors are Craig Alan Buchman, MD, Harold C. Pillsbury, MD and Jameson Kyle Mattingly, MD.

Dmand AI links Dr. Adunka to 5 clinical trials. 2 are still active or recruiting. Conditions studied include Hearing Loss, Mixed Conductive-Sensorineural, Hearing Loss and Hearing Loss, Conductive. Med-El Corporation sponsors the most, 2.

CMS Open Payments shows 156 general payments to Dr. Adunka from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 44% of the total. Advanced Bionics, LLC paid the most, $268,805. It also lists 1 research payment totaling $166,660 in 2018.

Dmand AI lists 4 awards for Dr. Adunka, most recently Best Doctors in 2018. Dr. Adunka serves on Implantable Hearing Devices and Equilibrium Committee.

Dr. Adunka graduated from University of Vienna Faculty of Medicine in 1999. Dr. Adunka is a member of NHS and ACS.

Dr. Adunka is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.